Screener
Disc Medicine IRON Debt-to-equity
Debt-to-equity at other companies
Other financials
Where this comes from
Calculated from Disc Medicine’s reported figures.
Based on the most recent quarter.
The source filing: Disc Medicine’s 10-Q, filed May 5, 2026. Open the filing →
- Filed
- May 5, 2026, 8:33 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205192
FAQ
- What is Disc Medicine's debt-to-equity?
- Disc Medicine (IRON) reported debt-to-equity of 0× in Q1 2026.
- How has Disc Medicine's debt-to-equity changed year-over-year?
- Disc Medicine's debt-to-equity decreased by 2.8% year-over-year, from 0× to 0×.
- What is the long-term trend for Disc Medicine's debt-to-equity?
- Over 3 years (2022 to 2025), Disc Medicine's debt-to-equity has grown at a 76.1% compound annual growth rate (CAGR), from 0× to 0×.
- What does debt-to-equity mean?
- Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.
Ask your AI about Disc Medicine's debt-to-equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude